Cancer Research and Biotechnology AG

HEALING THE

DISEASE THAT

CAUSES CANCER

HEALING THE DISEASE
THAT CAUSES CANCER

Cancer Research and Biotechnology AG (CRB) is a Swiss preclinical biotech company focusing on oncology and mitochondrial healing.

CRB develops small molecule drugs to reverse and restore the tumorigenic mitochondrial dysfunctions that cause cancer. We call it Reverse Carcinogenesis.

CRB has a clear vision to reverse carcinogenesis and a tactical roadmap in execution with an accelerated regulatory path to first human use in cancer.

CANCER IS NOT WHAT YOU THINK...

Cancer is not the same as a tumor. Instead, a tumor is caused by cancer. Cancer is the underlying disease (think of mushrooms in the forest).

Cancer is a long process, developing from birth to end of life, and eventually, it will lead to tumors.

Cancer is not genetic, with some exceptions.

WHAT IS THE Disease
THAT CAUSES CANCER?

Cancer is caused by the environmental harmful burden that accumulates in our cells over time, leading to mitochondrial dysfunctions, the root cause of cancer (as well as other serious diseases, such as Alzheimer’s, Parkinson’s, ALS, MS).

This causes failures in the complex intra- and extracellular defense systems that keep our cells healthy, and lead to uncontrolled cellular growth (tumorigenesis) and cellular spreading (metastasis).

CAN CANCER BE HEALED?

Yes.

There are many real-life cases where the disease has given up completely.

New cells are born healthy, and when they are protected from the cellular burdens, such as oxidative stress, ROS, heavy metals and radiation, they will not turn carcinogenic.

UNIQUE SOLUTION
IN CANCER TREATMENT

CRB has a clear vision to reverse carcinogenesis and a tactical roadmap in execution with an accelerated regulatory path to first human use in cancer.

DECADES OF RESEARCH

Profound discovery of reasons behind mitochondrial dysfunctions and a wide base of evidence distilled from existing research data

INNOVATIVE APPROACH

Platform innovation for novel treatments related to metabolism and mitochondria, and first targeting hard-to-treat cancers

REVERSE
CARCINO-GENESIS

Potential first-in-class: Reverse Carcinogenesis - reviving the body's innate immune system to fight carcinogenesis

FIRST
HUMAN USE

Visible path to first-in-human, today in preclinical studies of pancreatic cancer, triple-negative breast cancer, and colon cancer

MECHANISM
OF ACTION

Simple mechanism of action with effect on upstream carcinogenesis, development via expedited regulatory pathways

DRUG
DE-RISKED

Drug candidates are based on well-researched mechanisms and  pharmaceutical ingredients are already shown well-tolerated

JOIN US

PARTNER

Join our community
of partners
and experts

INVESTOR

Participate in the
journey of healing
cancer

CAREER

If you are smart and
exceptional, please
contact us

MISSION

TREAT AND PREVENT CANCERS BY FOCUSING ON METABOLIC ROOT CAUSES

VISION

OUR GOAL IS TO REVERSE TUMORIGENESIS

VALUES

COURAGE

EMPATHY

VALUE

PARTNERS